Uploaded March 2026 | Updated November 2026, 1 day ago
Adam Gries is a serial entrepreneur, software engineer, and prominent advocate in the longevity and vitalism movement. He has founded and sold four companies, including OKpanda and Material World, with his products reaching over 80 million users.
Gries is currently dedicated to the mission of ending aging and extending human healthspan.
0:00 Intro
0:53 Talk: Longevity and the Fight to Defy Aging
1:46 Who & how are we involved in longevity? (Adam Gries, Vitalism Foundation)
2:50 80% of us are on track to decline & die of aging - it's not a choice (for now) - Aging is the primary cause of death)
3:05 Aging is the #1 risk factor
3:57 Healthy aging is an oxymoron - we lose most of our capacity with aging
4:54 Humanity is fighting aging as hard as possible
6:33 Aging has economies on track to insolvency - we spend our money all wrong
7:41 Penny wise, pound foolish - Despite clear evidence aging is modifiable
9:23 As of 2025, 0 intervensions approved for aging in humans - so why is longevity suddenly so vogue?
9:51 Scientific progress, alongside an explosion of data, diagnostics and AI
10:36 Agenda: i) Do this now, ii) Existing innovation is great; but too little, iii) How we can still win
10:54 The Health Pyramid, know your data - supplements & biomarkers
12:50 Get a wearable, and track sleep
13:26 Get a DEXA scan, use CMG to understand blood glucose response
15:05 Check heart disease status, have a basic skincare routine
16:00 Ensure good air quality, do recommended tests for your age
16:47 Vo2 Max, full body MRI
19:50 Warnings
21:16 The health pyramid - make a plan - services that can help (including AI)
22:10 Best intervensions if already healthy? Excercise & nutrition - Warning: stemcells, peptides, exosomes
23:32 The health pyramid - do it - efforts can be delegated (but options are limited)
25:06 A couple of near-term concerns - presbyopia (treatment in development), ovarian cryopreservation
27:16 Hallmarks of aging and the statistical fact that risk rises with aging
28:54 What can existing interventions do? (how much life/healthspan can we achieve?)
32:22 How to guard against being unjustifiably ahead of the evidence
36:14 Longevity is an inevitable, massive growth opportunity - Longevity Biotech history
38:08 Longevity Biotech at a glance - Aging drug clinical trials - major funding is pouring in
39:32 GLP1 antagonists may be the first Longevity Therapy, PCSK9 inhibitor gene therapies
40:57 Longevity biotech Investor Landscape
46:21 Xenotransplantation, Xeno human organ growth, Embryonic Gene editing, Brainless clones (whole body transplants)
50:59 Section for Q&A
52:33 Regulation that doesn't strangle innovation
55:29 The need for quality data - AI labs working on aging
57:13 How we can still win? Attention upsteam of policy, money, and brains - money is never enough,
58:21 How to get a lot more attention
59:33 Comparing strategies to get more attention - building influence networks
1:04:17 Case study: tech libertarian influence network
1:06:48 Vitalism - longevity influence network
1:08:43 Vitalism grand strategy - we are in phase 2 - Vitalist Bay conference
1:11:15 What are you most excited about? Muscle preserving intervensions, some types of stem cell therapies, weight loss, gene therapies
1:14:47 Aging may require long trial phases
1:20:06 Non-partisan cross-party alignment
Many thanks for tuning in!
Please support SciFuture by subscribing and sharing!
Buy me a coffee? buymeacoffee.com/tech101z
Have any ideas about people to interview? Want to be notified about future events? Any comments about the STF series?
Please fill out this form: docs.google.com/forms/d/1mr9PIfq2ZYlQsXRIn5BcLH2onbiSI7g79mOH_AFCdIk
Kind regards,
Adam Ford
- Science, Technology & the Future - #SciFuture - scifuture.org
Adam Gries is a serial entrepreneur, software engineer, and prominent advocate in the longevity and vitalism movement. He has founded and sold four companies, including OKpanda and Material World, with his products reaching over 80 million users.
Gries is currently dedicated to the mission of ending aging and extending human healthspan.
0:00 Intro
0:53 Talk: Longevity and the Fight to Defy Aging
1:46 Who & how are we involved in longevity? (Adam Gries, Vitalism Foundation)
2:50 80% of us are on track to decline & die of aging - it's not a choice (for now) - Aging is the primary cause of death)
3:05 Aging is the #1 risk factor
3:57 Healthy aging is an oxymoron - we lose most of our capacity with aging
4:54 Humanity is fighting aging as hard as possible
6:33 Aging has economies on track to insolvency - we spend our money all wrong
7:41 Penny wise, pound foolish - Despite clear evidence aging is modifiable
9:23 As of 2025, 0 intervensions approved for aging in humans - so why is longevity suddenly so vogue?
9:51 Scientific progress, alongside an explosion of data, diagnostics and AI
10:36 Agenda: i) Do this now, ii) Existing innovation is great; but too little, iii) How we can still win
10:54 The Health Pyramid, know your data - supplements & biomarkers
12:50 Get a wearable, and track sleep
13:26 Get a DEXA scan, use CMG to understand blood glucose response
15:05 Check heart disease status, have a basic skincare routine
16:00 Ensure good air quality, do recommended tests for your age
16:47 Vo2 Max, full body MRI
19:50 Warnings
21:16 The health pyramid - make a plan - services that can help (including AI)
22:10 Best intervensions if already healthy? Excercise & nutrition - Warning: stemcells, peptides, exosomes
23:32 The health pyramid - do it - efforts can be delegated (but options are limited)
25:06 A couple of near-term concerns - presbyopia (treatment in development), ovarian cryopreservation
27:16 Hallmarks of aging and the statistical fact that risk rises with aging
28:54 What can existing interventions do? (how much life/healthspan can we achieve?)
32:22 How to guard against being unjustifiably ahead of the evidence
36:14 Longevity is an inevitable, massive growth opportunity - Longevity Biotech history
38:08 Longevity Biotech at a glance - Aging drug clinical trials - major funding is pouring in
39:32 GLP1 antagonists may be the first Longevity Therapy, PCSK9 inhibitor gene therapies
40:57 Longevity biotech Investor Landscape
46:21 Xenotransplantation, Xeno human organ growth, Embryonic Gene editing, Brainless clones (whole body transplants)
50:59 Section for Q&A
52:33 Regulation that doesn't strangle innovation
55:29 The need for quality data - AI labs working on aging
57:13 How we can still win? Attention upsteam of policy, money, and brains - money is never enough,
58:21 How to get a lot more attention
59:33 Comparing strategies to get more attention - building influence networks
1:04:17 Case study: tech libertarian influence network
1:06:48 Vitalism - longevity influence network
1:08:43 Vitalism grand strategy - we are in phase 2 - Vitalist Bay conference
1:11:15 What are you most excited about? Muscle preserving intervensions, some types of stem cell therapies, weight loss, gene therapies
1:14:47 Aging may require long trial phases
1:20:06 Non-partisan cross-party alignment
Many thanks for tuning in!
Please support SciFuture by subscribing and sharing!
Buy me a coffee? buymeacoffee.com/tech101z
Have any ideas about people to interview? Want to be notified about future events? Any comments about the STF series?
Please fill out this form: docs.google.com/forms/d/1mr9PIfq2ZYlQsXRIn5BcLH2onbiSI7g79mOH_AFCdIk
Kind regards,
Adam Ford
- Science, Technology & the Future - #SciFuture - scifuture.org
![Wendell Wallach - AI and the Silent Ethic #AI #Ethics #aiethics
In this video, Wendell Wallach discusses the relationship between AI governance, silent ethics, and trade-off ethics. He explores whether institutional systems and artificial intelligence can approximate a moral sense through data and analysis.
Key Takeaways:
- AI as an Analytical Equivalent to Silent Ethics: Wallach suggests that if an AI has access to complete information and performs a thorough analysis, the most ethical course of action often becomes apparent [00:41]. This analytical clarity serves as a functional equivalent to the silent ethic—a concept usually rooted in human moral intuition [01:22].
- The Intersection of Moral Psychology and Analysis: He emphasises that silent ethics and trade-off ethics are complementary. In his view, true moral intelligence requires both internal moral psychology (self-understanding) and rigorous moral analysis (calculating benefits and harms) [01:48].
- The Role of Human Actors in Institutions: When asked if institutions can possess self-understanding, Wallach points out that organisations are ultimately collections of individuals. An institution’s ethical standing is only as strong as the human actors within it and their ability to embody and pass down its core values to the next generation [02:48].
Wendell Wallach (born 21 April 1946) is a world-renowned bioethicist and expert on the ethics and governance of emerging technologies, particularly artificial intelligence (AI) and neuroscience. Often referred to as a godfather of AI ethics, his work focuses on the challenges of aligning rapidly advancing systems with human values.
# Current Roles & Affiliations:
Wallach remains active in several prestigious academic and policy institutions:
- Yale University: Emeritus Scholar at the Interdisciplinary Center for Bioethics, where he chaired the Technology and Ethics study group for 11 years.
- Carnegie Council for Ethics in International Affairs: Carnegie-Uehiro Senior Fellow and co-director of the AI & Equality Initiative (AIEI), which addresses structural inequalities driven by AI.
- The Hastings Center: Senior Advisor for this nonpartisan research institute focused on the social and ethical issues of science and health.
- Other Fellows: Fellow at the Sandra Day O’Connor School of Law (Arizona State University) and the Institute for Ethics & Emerging Technology.Key Publications
# He has authored several foundational works that helped define the field of machine ethics:
- Moral Machines: Teaching Robots Right from Wrong (2008): Co-authored with Colin Allen, this is widely considered the first book to examine the challenge of building artificial moral agents.
- A Dangerous Master: How to Keep Technology from Slipping Beyond Our Control (2015): Explores the risks of unchecked technological development and proposes governance solutions. A revised edition with a new preface was released in 2024.
- Library of Essays on Ethics and Emerging Technologies: Series editor for this comprehensive eight-volume collection published by Routledge.
# Global Policy & Influence
Wallach has a significant presence in international policy forums:United Nations: Has provided testimony to the UN on lethal autonomous weapons systems and advised on digital cooperation.
World Economic Forum (WEF): Formerly co-chaired the Global Future Council on Technology, Values, and Policy and served on the AI Council.
# Awards: Recipient of the World Technology Network awards for Ethics (2014) and Journalism & Media (2015).
#moralmachines #MachineEthics #AI
Many thanks for tuning in!
Please support SciFuture by subscribing and sharing!
Buy me a coffee? https://buymeacoffee.com/tech101z
Have any ideas about people to interview? Want to be notified about future events? Any comments about the STF series?
Please fill out this form: https://docs.google.com/forms/d/1mr9PIfq2ZYlQsXRIn5BcLH2onbiSI7g79mOH_AFCdIk/
Kind regards,
Adam Ford
- Science, Technology & the Future - #SciFuture - http://scifuture.org Wendell Wallach - AI and the Silent Ethic #AI #Ethics #aiethics](https://i.ytimg.com/vi/hReugvhIGsE/mqdefault.jpg)









